Idexx Laboratories (IDXX) — insider trading
Health Care · NASDAQ
Idexx Laboratories (IDXX) has 45 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 45 (latest 2026-09-04).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-04 | Kingsley Lawrence D | Director | Option exercise / conversion (derivative) | 2,203 | — | — | Form 4 |
| 2026-09-04 | Kingsley Lawrence D | Director | Open-market sale | 2,203 | $532.08 | $1.17M | Form 4 |
| 2026-09-04 | Kingsley Lawrence D | Director | Option exercise / conversion | 2,203 | $114.17 | $251.5K | Form 4 |
| 2026-08-20 | Emerson Andrew | Officer (EVP, CFO and Treasurer) | Option exercise / conversion (derivative) | 265 | — | — | Form 4 |
| 2026-08-20 | Emerson Andrew | Officer (EVP, CFO and Treasurer) | Shares withheld for taxes / exercise cost | 86 | — | $0 | Form 4 |
| 2026-08-20 | Emerson Andrew | Officer (EVP, CFO and Treasurer) | Option exercise / conversion | 265 | $178.26 | $47.2K | Form 4 |
| 2026-07-30 | HOOLEY JOSEPH L | Director | Grant / award / vesting | 49 | $558.80 | $27.4K | Form 4 |
| 2026-06-01 | FENNELL GEORGE | Officer (Executive Vice President) | Option exercise / conversion (derivative) | 639 | — | — | Form 4 |
| 2026-06-01 | FENNELL GEORGE | Officer (Executive Vice President) | Shares withheld for taxes / exercise cost | 284 | $566.79 | $161.0K | Form 4 |
| 2026-06-01 | FENNELL GEORGE | Officer (Executive Vice President) | Option exercise / conversion | 639 | — | $0 | Form 4 |
| 2026-05-12 | Britt Irene Chang | Director | Grant / award / vesting (derivative) | 234 | — | $0 | Form 4 |
| 2026-05-12 | Britt Irene Chang | Director | Grant / award / vesting (derivative) | 525 | — | $0 | Form 4 |
| 2026-05-12 | Claflin Bruce L. | Director | Grant / award / vesting (derivative) | 234 | — | $0 | Form 4 |
| 2026-05-12 | Claflin Bruce L. | Director | Grant / award / vesting (derivative) | 525 | — | $0 | Form 4 |
| 2026-05-12 | ESSIG STUART | Director | Grant / award / vesting (derivative) | 234 | — | $0 | Form 4 |
| 2026-05-12 | ESSIG STUART | Director | Grant / award / vesting (derivative) | 525 | — | $0 | Form 4 |
| 2026-05-12 | HOOLEY JOSEPH L | Director | Grant / award / vesting (derivative) | 234 | — | $0 | Form 4 |
| 2026-05-12 | HOOLEY JOSEPH L | Director | Grant / award / vesting (derivative) | 525 | — | $0 | Form 4 |
| 2026-05-12 | JUNIUS DANIEL M | Director | Grant / award / vesting (derivative) | 234 | — | $0 | Form 4 |
| 2026-05-12 | JUNIUS DANIEL M | Director | Grant / award / vesting (derivative) | 525 | — | $0 | Form 4 |
| 2026-05-12 | Kingsley Lawrence D | Director | Grant / award / vesting (derivative) | 75 | — | $0 | Form 4 |
| 2026-05-12 | Kingsley Lawrence D | Director | Grant / award / vesting (derivative) | 234 | — | $0 | Form 4 |
| 2026-05-12 | Kingsley Lawrence D | Director | Grant / award / vesting (derivative) | 168 | — | $0 | Form 4 |
| 2026-05-12 | Kingsley Lawrence D | Director | Grant / award / vesting (derivative) | 525 | — | $0 | Form 4 |
| 2026-05-12 | Peacock Karen | Director | Grant / award / vesting (derivative) | 234 | — | $0 | Form 4 |
| 2026-05-12 | Peacock Karen | Director | Grant / award / vesting (derivative) | 525 | — | $0 | Form 4 |
| 2026-05-12 | SAMAD SAM | Director | Grant / award / vesting (derivative) | 234 | — | $0 | Form 4 |
| 2026-05-12 | SAMAD SAM | Director | Grant / award / vesting (derivative) | 525 | — | $0 | Form 4 |
| 2026-05-12 | Vandebroek Sophie V. | Director | Grant / award / vesting (derivative) | 234 | — | $0 | Form 4 |
| 2026-05-12 | Vandebroek Sophie V. | Director | Grant / award / vesting (derivative) | 525 | — | $0 | Form 4 |
| 2026-05-07 | HOOLEY JOSEPH L | Director | Option exercise / conversion (derivative) | 158 | — | — | Form 4 |
| 2026-05-07 | HOOLEY JOSEPH L | Director | Option exercise / conversion | 158 | — | $0 | Form 4 |
| 2026-05-07 | JUNIUS DANIEL M | Director | Option exercise / conversion (derivative) | 257 | — | — | Form 4 |
| 2026-05-07 | JUNIUS DANIEL M | Director | Option exercise / conversion | 257 | — | $0 | Form 4 |
| 2026-05-07 | Kingsley Lawrence D | Director | Option exercise / conversion (derivative) | 82 | — | — | Form 4 |
| 2026-05-07 | Kingsley Lawrence D | Director | Option exercise / conversion (derivative) | 257 | — | — | Form 4 |
| 2026-05-07 | Kingsley Lawrence D | Director | Option exercise / conversion | 82 | — | $0 | Form 4 |
| 2026-05-07 | Kingsley Lawrence D | Director | Option exercise / conversion | 257 | — | $0 | Form 4 |
| 2026-05-07 | Peacock Karen | Director | Option exercise / conversion (derivative) | 101 | — | — | Form 4 |
| 2026-05-07 | Peacock Karen | Director | Option exercise / conversion | 101 | — | $0 | Form 4 |
| 2026-05-07 | SZOSTAK M ANNE | Director | Option exercise / conversion (derivative) | 257 | — | — | Form 4 |
| 2026-05-07 | SZOSTAK M ANNE | Director | Option exercise / conversion | 257 | — | $0 | Form 4 |
| 2026-05-07 | Vandebroek Sophie V. | Director | Option exercise / conversion (derivative) | 257 | — | — | Form 4 |
| 2026-05-07 | Vandebroek Sophie V. | Director | Option exercise / conversion | 257 | — | $0 | Form 4 |
| 2026-04-30 | HOOLEY JOSEPH L | Director | Grant / award / vesting | 43 | $560.80 | $24.1K | Form 4 |
Ask the chat about IDXX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Idexx Laboratories (IDXX).
Last updated 2026-09-04 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.